Salinomycin Radiosensitizes Human Nasopharyngeal Carcinoma Cell Line CNE-2 to Radiation
Overview
Authors
Affiliations
Nasopharyngeal carcinoma (NPC) is primarily treated by chemoradiation. However, how to promote radiation sensitivity in NPC remains a challenge. Salinomycin is potentially useful for the treatment of cancer. This study aimed to explore the radiosensitivity of salinomycin on human nasopharyngeal carcinoma cell line CNE-2. CNE-2 were treated with salinomycin or irradiation, alone or in combination. The cytotoxicity effects of salinomycin were measured using CCK-8 assay. Clonogenic survival assay was used to evaluate the effects of salinomycin on the radiosensitivity of CNE-2. The changes of cell cycle distribution and apoptosis were assayed using flow cytometry. The expression of Caspase3/Bax/Bal-2 was detected by Western blotting. DNA damage was detected via γ-H2AX foci counting. The results showed that salinomycin induced apoptosis and G2/M arrest, increased Bax and cleaved Caspase3, decreased Bcl-2 expression, and increased the formation of γ-H2AX nuclear foci. These data suggest that salinomycin may be a radiosensitizer for NPC radiotherapy.
Radiosensitivity-Related Genes and Clinical Characteristics of Nasopharyngeal Carcinoma.
Dai Y, Zhang Y, Yang M, Zhou L, Pan H, Xiao T Biomed Res Int. 2020; 2020:1705867.
PMID: 33299859 PMC: 7704138. DOI: 10.1155/2020/1705867.
Fu C, Wang L, Tian G, Zhang C, Zhao Y, Xu H Oncol Lett. 2019; 17(2):1798-1806.
PMID: 30675240 PMC: 6341778. DOI: 10.3892/ol.2018.9796.
Ji Y, Li H, Wang F, Gu L Front Pharmacol. 2018; 9:648.
PMID: 30002625 PMC: 6031703. DOI: 10.3389/fphar.2018.00648.
Salinomycin, as an autophagy modulator-- a new avenue to anticancer: a review.
Jiang J, Li H, Qaed E, Zhang J, Song Y, Wu R J Exp Clin Cancer Res. 2018; 37(1):26.
PMID: 29433536 PMC: 5809980. DOI: 10.1186/s13046-018-0680-z.
Effects of salinomycin and 17‑AAG on proliferation of human gastric cancer cells in vitro.
Zhang Z, Zhao J, Mi Z, Pang Q, Wang A, Chen M Mol Med Rep. 2017; 16(2):1063-1070.
PMID: 28627587 PMC: 5562019. DOI: 10.3892/mmr.2017.6735.